Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Mitchell Blutt’

MNK Q2 16 Ownership

Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns

The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can......(read more)
healthcare

Healthcare Fund Consonance Capital’s Top Picks For Q3 Following Monster First Half

The healthcare sector has appreciated by more than 14% so far this year, so we decided to take a look at how healthcare funds are gearing their portfolios......(read more)
Akorn, Inc. (NASDAQ:AKRX)

Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare

The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain......(read more)
Mario Gabelli

BioScrip Inc (BIOS): GAMCO Investors Still Bullish and Buys More Shares

GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased......(read more)
Mario Gabelli

BioScrip Inc (BIOS), Proteon Therapeutics Inc (PRTO): GAMCO Investors and Deerfield Management Are Bullish on These Companies

Mario Gabelli’s GAMCO Investors and James E. Flynn’s Deerfield Management seem bullish on BioScrip Inc (NASDAQ:BIOS) and Proteon Therapeutics Inc (......(read more)
Furiex Pharmaceuticals Inc (FURX)

Furiex Pharmaceuticals Inc. (FURX): Magnetar Capital Reveals 10% Stake; Garnero Group Acquisition Co. (GGACU): Glazer Capital Reports 6% Stake

In a new filing with the U.S. Securities and Exchange Commission, Magnetar Capital, run by Alec Litowitz and Ross Laser, has disclosed a new position......(read more)
United Therapeutics Corporation (NASDAQ:UTHR)

Consonance Capital Management is Fond of Healthcare Stocks

Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower......(read more)
Orthofix International NV (NASDAQ:OFIX)

Conan Laughlin’s North Tide Capital Reports 6% Passive Stake In Orthofix International NV (OFIX)

Conan Laughlin’s North Tide Capital has revealed holding 1.09 million shares of Orthofix International NV (NASDAQ:OFIX). The position represents 5.99......(read more)
Peter Kolchinsky

Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)

Peter Kolchinsky‘s Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). According to a 13G filing, the......(read more)
Visium Asset Management

Visium Asset Management’s Latest Purchase: AMAG Pharmaceuticals Inc. (AMAG)

Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc. (......(read more)